|
Royal Pharmaceutical Society's Chief Scientist Gino Martini chats with Nathalie Moll and Sunayana Shah about lessons learnt from COVID-19, how the industry is getting prepared to tackle future health threats such as AMR, and about the exciting innovations in the R&D pipeline.
|